{"Title": "Corticosteroids for Urological Cancer Care During Coronavirus Disease 2019. Treat or Not to Treat?", "Year": 2020, "Source": "Eur. Urol.", "Volume": "78", "Issue": 1, "Art.No": null, "PageStart": 9, "PageEnd": 10, "CitedBy": 1, "DOI": "10.1016/j.eururo.2020.04.027", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85083706148&origin=inward", "Abstract": "\u00a9 2020 European Association of UrologyThe current World Health Organization guidance is not to start corticosteroids, but there is no robust evidence of risk in patients with cancer and coronavirus disease 2019. A risk-benefit analysis should be performed for each patient on the use of steroids in cancer care.", "AuthorKeywords": null, "IndexKeywords": ["Adrenal Cortex Hormones", "Antineoplastic Agents, Hormonal", "Antineoplastic Agents, Immunological", "Betacoronavirus", "Capillary Leak Syndrome", "Coronavirus Infections", "Female", "Humans", "Inflammation", "Kidney Neoplasms", "Male", "Pandemics", "Pneumonia, Viral", "Practice Guidelines as Topic", "Prostatic Neoplasms", "Risk Assessment", "Risk Factors", "Urinary Bladder Neoplasms", "Urologic Neoplasms"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 2, "EID": "2-s2.0-85083706148", "SubjectAreas": [["Urology", "MEDI", "2748"]], "AuthorData": {"57216503190": {"Name": "Waterhouse J.V.", "AuthorID": "57216503190", "AffiliationID": "60022148", "AffiliationName": "Department of Oncology, University College London Cancer Institute"}, "23489393000": {"Name": "Linch M.", "AuthorID": "23489393000", "AffiliationID": "60022148", "AffiliationName": "Department of Oncology, University College London Cancer Institute"}, "55433702300": {"Name": "Hull J.H.", "AuthorID": "55433702300", "AffiliationID": "60009009, 60015150", "AffiliationName": "Department of Respiratory Medicine, Royal Brompton Hospital, Imperial College"}}}